Chronic Kidney Disease Alters Vitamin A Homeostasis via Effects on Hepatic RBP4 Protein Expression and Metabolic Enzymes. Issue 4 (9th June 2016)

• Record Type: Journal Article
• Authors: Jing, J; Isoherranen, N; Robinson‐Cohen, C; Petrie, I; Kestenbaum, BR; Yeung, CK
• Is Part Of: Clinical and translational science. Volume 9:Issue 4(2016)
• Page Start: 207
• Page End: 215
• Publication Date: 2016-06-09
• Subjects: Medicine, Experimental -- Periodicals; Medical innovations -- Periodicals; 616.027
• DOI: 10.1111/cts.12402
• Languages: English
• ISSNs: 1752-8054

Abstract

Abstract : Vitamin A, via retinoic acid (RA), is a critical micronutrient. Normally, plasma concentrations are tightly regulated. Concentrations of vitamin A metabolites (13 cis ‐RA, at RA) and relationships between RBP4 and retinoids have never been fully evaluated in adult patients with CKD. We measured retinoid and RBP4 concentrations in plasma and urine from 55 adult patients with CKD and 21 matched healthy subjects. RBP4 and retinol levels were increased approximately twofold in patients with CKD, with a negative correlation between plasma retinol and eGFR ( p = 0.006) and plasma RBP4 and eGFR ( p = 0.0007). RBP4 renal clearance was higher in patients with CKD than healthy subjects but not associated with eGFR. Circulating concentrations of at RA increased and concentrations of 13 cis ‐RA decreased in subjects with CKD with no change in RA‐to‐retinol ratio. Increases in circulating retinol, RBP4, and at RA may be due to increased hepatic RBP4 synthesis, retinyl ester hydrolysis, and/or hepatic secretion of RBP4‐retinol.